93 related articles for article (PubMed ID: 10617296)
1. P0 protein mediated targeting of liposomes to melanoma cells with high level of ICAM-1 expression.
Jaafari MR; Foldvari M
J Drug Target; 1999; 7(2):101-12. PubMed ID: 10617296
[TBL] [Abstract][Full Text] [Related]
2. Targeting liposomes through immunoglobulin superfamily domains: P0 protein as a model.
Foldvari M; Jaafari MR; Mezei M; Mezei C
Drug Deliv; 1998; 5(3):183-95. PubMed ID: 19569984
[TBL] [Abstract][Full Text] [Related]
3. Targeting of liposomes to melanoma cells with high levels of ICAM-1 expression through adhesive peptides from immunoglobulin domains.
Jaafari MR; Foldvari M
J Pharm Sci; 2002 Feb; 91(2):396-404. PubMed ID: 11835199
[TBL] [Abstract][Full Text] [Related]
4. Intracellular delivery of drugs by liposomes containing P0 glycoprotein from peripheral nerve myelin into human M21 melanoma cells.
Foldvari M; Mezei C; Mezei M
J Pharm Sci; 1991 Nov; 80(11):1020-8. PubMed ID: 1726112
[TBL] [Abstract][Full Text] [Related]
5. Enhanced metastatic ability of TNF-alpha-treated malignant melanoma cells is reduced by intercellular adhesion molecule-1 (ICAM-1, CD54) antisense oligonucleotides.
Miele ME; Bennett CF; Miller BE; Welch DR
Exp Cell Res; 1994 Sep; 214(1):231-41. PubMed ID: 7915992
[TBL] [Abstract][Full Text] [Related]
6. Circulating IgSF proteins inhibit adhesion of antibody targeted microspheres to endothelial inflammatory ligands.
Kerby MB; Urban JC; Mouallem L; Tripathi A
Appl Biochem Biotechnol; 2009 Oct; 159(1):208-20. PubMed ID: 19140030
[TBL] [Abstract][Full Text] [Related]
7. Human interleukin for DA cells/leukemia inhibitory factor and oncostatin M enhance membrane expression of intercellular adhesion molecule-1 on melanoma cells but not the shedding of its soluble form.
Heymann D; Godard A; Raher S; Ringeard S; Lassort D; Blanchard F; Harb J
Cytokine; 1995 Feb; 7(2):111-7. PubMed ID: 7780030
[TBL] [Abstract][Full Text] [Related]
8. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
9. Role of myelin P0 protein as a homophilic adhesion molecule.
Filbin MT; Walsh FS; Trapp BD; Pizzey JA; Tennekoon GI
Nature; 1990 Apr; 344(6269):871-2. PubMed ID: 1691824
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of alpha(v)beta3 integrin and intercellular adhesion molecule-1 expression in cutaneous malignant melanoma lesions.
Natali PG; Hamby CV; Felding-Habermann B; Liang B; Nicotra MR; Di Filippo F; Giannarelli D; Temponi M; Ferrone S
Cancer Res; 1997 Apr; 57(8):1554-60. PubMed ID: 9108459
[TBL] [Abstract][Full Text] [Related]
11. Myelin P0-protein, more than just a structural protein?
Filbin MT; Tennekoon GI
Bioessays; 1992 Aug; 14(8):541-7. PubMed ID: 1285424
[TBL] [Abstract][Full Text] [Related]
12. Comparative proteomics of the Mycobacterium leprae binding protein myelin P0: its implication in leprosy and other neurodegenerative diseases.
Vardhini D; Suneetha S; Ahmed N; Joshi DS; Karuna S; Magee X; Vijayalakshmi DS; Sridhar V; Karunakar KV; Archelos JJ; Suneetha LM
Infect Genet Evol; 2004 Mar; 4(1):21-8. PubMed ID: 15019586
[TBL] [Abstract][Full Text] [Related]
13. L2/HNK-1 carbohydrate and protein-protein interactions mediate the homophilic binding of the neural adhesion molecule P0.
Griffith LS; Schmitz B; Schachner M
J Neurosci Res; 1992 Dec; 33(4):639-48. PubMed ID: 1282935
[TBL] [Abstract][Full Text] [Related]
14. Regulation of myelin-specific gene expression. Relevance to CMT1.
Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
[TBL] [Abstract][Full Text] [Related]
15. Targeting of ICAM-1-directed immunoliposomes specifically to activated endothelial cells with low cellular uptake: use of an optimized procedure for the coupling of low concentrations of antibody to liposomes.
Hua S; Chang HI; Davies NM; Cabot PJ
J Liposome Res; 2011 Jun; 21(2):95-105. PubMed ID: 20429814
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the effect on adhesion of different mutations in myelin P0 protein.
Filbin MT; Zhang K; Li W; Gao Y
Ann N Y Acad Sci; 1999 Sep; 883():160-7. PubMed ID: 10586242
[TBL] [Abstract][Full Text] [Related]
17. Increased P0 glycoprotein gene expression in primary and transfected rat Schwann cells after treatment with axolemma-enriched fraction.
Knight RM; Fossom LH; Neuberger TJ; Attema BL; Tennekoon G; Bharucha V; DeVries GH
J Neurosci Res; 1993 May; 35(1):38-45. PubMed ID: 7685396
[TBL] [Abstract][Full Text] [Related]
18. Protein zero is necessary for E-cadherin-mediated adherens junction formation in Schwann cells.
Menichella DM; Arroyo EJ; Awatramani R; Xu T; Baron P; Vallat JM; Balsamo J; Lilien J; Scarlato G; Kamholz J; Scherer SS; Shy ME
Mol Cell Neurosci; 2001 Dec; 18(6):606-18. PubMed ID: 11749037
[TBL] [Abstract][Full Text] [Related]
19. Genetic engineering, expression, and activity of a chimeric monoclonal antibody-avidin fusion protein for receptor-mediated delivery of biotinylated drugs in humans.
Boado RJ; Zhang Y; Zhang Y; Xia CF; Wang Y; Pardridge WM
Bioconjug Chem; 2008 Mar; 19(3):731-9. PubMed ID: 18278853
[TBL] [Abstract][Full Text] [Related]
20. The role of human melanoma cell ICAM-1 expression on lymphokine activated killer cell-mediated lysis, and the effect of retinoic acid.
Alexander CL; Edward M; MacKie RM
Br J Cancer; 1999 Jul; 80(10):1494-500. PubMed ID: 10408388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
